Skip to main content

PGD conditions

This table shows all PGD conditions currently approved and awaiting consideration by the HFEA.

Please note that we are updating this database, and some approved conditions may not be displayed. If you are unsure if a condition has been approved or not, please contact pgd@hfea.gov.uk.

Condition name Status OMIM number Documents
Palmoplantar Keratoderma, Nonepidermolytic, Focal or Diffuse approved 615735
Paragangliomas 4 (PGL4) approved 115310
Paramyotonia Congenita (PMC) approved 168300
Paramyotonia Congenita of von Eulenburg approved 168300
Parkinson’s disease 1 approved 168601
Parkinson’s disease 4 approved 605543
Parkinson's disease 8 approved 607060
Paroxysmal extreme pain disorder (PEPD) approved 167400
Partial androgen insensitivity syndrome due to defects in the androgen receptor gene approved 312300
Partial Lipodystrophy, Familial Type 2 (FPLD2) approved 151660
Partner and Localizer of BRCA2 (PALB2) approved 610355
Pelizaeus Merzbacher Disease approved 312080
Pendred Syndrome (PDS) approved 274600
Peroxisome Biogenesis Disorders (PBD) (Zellweger Syndrome Spectrum (ZSS)) approved
Pettigrew syndrome approved 304340
Peutz-Jeghers Syndrome (PJS) approved 175200
Pfeiffer syndrome, OMIM approved 101600
Phenylketonuria (PKU) approved 261600
Photosensitive Trichothiodystrophy 1 (TTD1) approved 601675
Pituitary Adenoma Type 1 approved 102200